Skip to main content

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • RDIF and Stelis Biopharma partner to supply 200 million doses of the Sputnik V vaccine

    The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Stelis Biopharma Pvt. Ltd., the biopharmaceutical division of Strides, a global pharmaceutical company headquartered in India, have partnered to produce, and supply a minimum of 200 million doses of the Russian Sputnik V vaccine against coronavirus sufficient to vaccinate 100 million people. The agreement between RDIF and Stelis Biopharma was reached under the aegis of Enso Healthcare LLP (part of Enso Group), RDIF's coordination partner for sourcing Sputnik V vaccines in India.

  • Ultrasound has potential to damage coronaviruses : Study finds
    Ultrasound has potential to damage coronaviruses : Study finds

    The coronavirus’ structure is an all-too-familiar image, with its densely packed surface receptors resembling a thorny crown. These spike-like proteins latch onto healthy cells and trigger the invasion of viral RNA. While the virus’ geometry and infection strategy is generally understood, little is known about its physical integrity.

  • Vaccines alone may not be enough to end pandemic
    Vaccines alone may not be enough to end pandemic

    Even as vaccines are becoming more readily available in the U.S., protecting against the asymptomatic and pre-symptomatic spread of the virus (SARS-CoV-2) that causes COVID-19 is key to ending the pandemic, say two Georgetown infectious disease experts.

  • MHRA response to the precautionary suspensions of COVID-19 Vaccine AstraZeneca
    MHRA response to the precautionary suspensions of COVID-19 Vaccine AstraZeneca

    It has not been confirmed that the reports of blood clots were caused by the AstraZeneca COVID-19 vaccine. People should still go and get their COVID-19 vaccine when asked to do so.

    Dr Phil Bryan, MHRA Vaccines Safety Lead said:
    The benefits of the vaccine in preventing COVID-19, with its associated risk of hospitalisation and death, far outweigh the risks of side effects. People should go and get their COVID-19 vaccine when asked to do so

  • New class of substances for redox reactions
    New class of substances for redox reactions

    Redox reactions play an important role in our everyday life. In these reactions, one compound releases electrons and is oxidized, while another accepts electrons and is reduced. Such redox reactions are exploited by living organisms, for example, to store energy.

  • Enzymatic danse macabre of lung cancer
    Enzymatic danse macabre of lung cancer

    A chromatin-regulating enzyme has been shown by in-depth interdisciplinary investigations to be a key driver of a common type of lung cancer. Drugs that target the enzyme could improve treatment and survival rates for this particular cancer.

  • Amalaki Rasayana is effective in cardiac hypertrophy, says Research
    Amalaki Rasayana is effective in cardiac hypertrophy, says Research

    Using the integrated approach of cheminformatics and network systems biology, Researchers from IIT Guwahati investigated Amalaki Rasayana (AR), an Ayurvedic rejuvenate for the treatment of cardiovascular diseases such as pressure-overload left ventricular cardiac hypertrophy (LVCH). The study has been published in the Nature Partnership Journal System Biology and Applications.

  • Raw drug repository for medicinal herbs established in CSIR-NBRI
    Raw drug repository for medicinal herbs established in CSIR-NBRI

    The National Botanical Research Institute (NBRI), a Lucknow-based constituent laboratory of the Council of Scientific and Industrial Research (CSIR), is known for its research and development related to various botanical disciplines. A broad spectrum of research activities is being conducted at CSIR-NBRI, which includes plant diversity, systematics and herbarium, pharmacognosy, phytochemistry, plant ecology, environmental technologies, molecular biology, biotechnology, plant genetic resources, plant conservation, and agro-technologies.

  • Masimo EMMA Portable Capnograph useful for assessment of the respiratory condition in children
    Masimo EMMA Portable Capnograph useful for assessment of the respiratory condition in children

    Masimo announced the findings of an observational, retrospective study published in Pediatrics International. In the study, researchers at the Osaka Women’s and Children’s Hospital in Japan found the Masimo EMMA® Portable Capnograph “useful for assessment of the respiratory condition in children with tracheostomy.” EMMA® provides seamless mainstream capnography for patients of all ages in a compact, easily portable device.

  • Max Healthcare raises Rs. 1200 crore through QIP
    Max Healthcare raises Rs. 1200 crore through QIP

    Max Healthcare Institute Ltd (MHC), India’s second largest private hospital chain operator by revenue in Fiscal 2020 announced the successful completion of its Qualified Institutions Placement (QIP). MHC raised INR 1,200 Cr (approx. USD 165 Mn) through its QIP, which saw participation from highly reputable global and domestic investors. MHC has accordingly issued 6,14,12,482 fresh equity shares of face value of INR 10 per equity share at a price of INR 195.40 per equity share.

Subscribe to Pharma News